As advanced therapy technology and manufacturing evolve, there are three key operational challenges to address unique to these products.
Erin Finot
Advertisement
Articles by Erin Finot
Erin Finot, Global Head of Immuno-Oncology at IQVIA Biotech, discusses the immense challenges to overcome before advanced therapies become more widespread.
Advertisement
Latest Updated Articles
Top Three Sources of Operational Complexity in Cell and Gene Therapy Clinical TrialsPublished: September 4th 2019 | Updated:
- Operational Complexity in Cell and Gene Therapy Trials
Published: October 1st 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Streamlining Clinical Data to Reduce Site and Participant Burden
3
Utilizing Tech Tools to Accelerate Drug Development
4
ACT Brief: Lilly Seeks FDA Priority Review for Oral GLP-1 as Bispecific Antibody Trials Redefine Ethical Standards
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
